Han E, Lee S, Park K, Blum I, Liu Q, Mehta A
J Neurosci. 2024; 44(18).
PMID: 38485259
PMC: 11063825.
DOI: 10.1523/JNEUROSCI.0389-23.2024.
Perez R, Yang X, Familari M, Martinez G, Lovicu F, Hime G
J Mol Histol. 2024; 55(1):121-138.
PMID: 38165569
DOI: 10.1007/s10735-023-10177-y.
Jiang Y, Yuan X, Li B, Liu M, Shi Y, Feng J
J Assist Reprod Genet. 2021; 38(10):2641-2650.
PMID: 34718923
PMC: 8581109.
DOI: 10.1007/s10815-021-02277-z.
Yang Y, Shen X, Sun K
Int J Clin Exp Pathol. 2020; 11(8):4060-4066.
PMID: 31949796
PMC: 6962808.
Bai Y, Qiao L, Xie N, Li Y, Nie Y, Pan Y
Cancer Med. 2020; 9(4):1503-1514.
PMID: 31891232
PMC: 7013073.
DOI: 10.1002/cam4.2756.
High expression of Tob1 indicates poor survival outcome and promotes tumour progression via a Wnt positive feedback loop in colon cancer.
Li D, Xiao L, Ge Y, Fu Y, Zhang W, Cao H
Mol Cancer. 2018; 17(1):159.
PMID: 30447686
PMC: 6240287.
DOI: 10.1186/s12943-018-0907-9.
Decreased TOB1 expression and increased phosphorylation of nuclear TOB1 promotes gastric cancer.
Guan R, Peng L, Wang D, He H, Wang D, Zhang R
Oncotarget. 2017; 8(43):75243-75253.
PMID: 29088861
PMC: 5650416.
DOI: 10.18632/oncotarget.20749.
MiR-4295 promotes cell growth in bladder cancer by targeting BTG1.
Nan Y, Wang J, Wang Y, Sun P, Han Y, Fan L
Am J Transl Res. 2016; 8(11):4892-4901.
PMID: 27904689
PMC: 5126331.
Immune cell-specific transcriptional profiling highlights distinct molecular pathways controlled by Tob1 upon experimental autoimmune encephalomyelitis.
Didonna A, Cekanaviciute E, Oksenberg J, Baranzini S
Sci Rep. 2016; 6:31603.
PMID: 27546286
PMC: 4992865.
DOI: 10.1038/srep31603.
BTG1 might be employed as a biomarker for carcinogenesis and a target for gene therapy in colorectal cancers.
Zhao S, Chen S, Yang X, Shen D, Takano Y, Su R
Oncotarget. 2016; 8(5):7502-7520.
PMID: 27447746
PMC: 5352338.
DOI: 10.18632/oncotarget.10649.
Transducer of ERBB2.1 (TOB1) as a Tumor Suppressor: A Mechanistic Perspective.
Lee H, Kundu J, Kim R, Shin Y
Int J Mol Sci. 2015; 16(12):29815-28.
PMID: 26694352
PMC: 4691146.
DOI: 10.3390/ijms161226203.
BTG1 expression correlates with pathogenesis, aggressive behaviors and prognosis of gastric cancer: a potential target for gene therapy.
Zheng H, Li J, Shen D, Yang X, Zhao S, Wu Y
Oncotarget. 2015; 6(23):19685-705.
PMID: 26050197
PMC: 4637314.
DOI: 10.18632/oncotarget.4081.
The roles of BTG3 expression in gastric cancer: a potential marker for carcinogenesis and a target molecule for gene therapy.
Gou W, Yang X, Shen D, Zhao S, Liu Y, Sun H
Oncotarget. 2015; 6(23):19841-67.
PMID: 25904053
PMC: 4637325.
DOI: 10.18632/oncotarget.3734.
Diversity of clinical implication of B-cell translocation gene 1 expression by histopathologic and anatomic subtypes of gastric cancer.
Kanda M, Oya H, Nomoto S, Takami H, Shimizu D, Hashimoto R
Dig Dis Sci. 2014; 60(5):1256-64.
PMID: 25487193
DOI: 10.1007/s10620-014-3477-8.
The role of antiproliferative gene Tob1 in the immune system.
Baranzini S
Clin Exp Neuroimmunol. 2014; 5(2):132-136.
PMID: 25071870
PMC: 4111268.
DOI: 10.1111/cen3.12125.
BTG1 expression correlates with the pathogenesis and progression of ovarian carcinomas.
Zhao Y, Gou W, Chen S, Takano Y, Xiu Y, Zheng H
Int J Mol Sci. 2013; 14(10):19670-80.
PMID: 24084718
PMC: 3821579.
DOI: 10.3390/ijms141019670.
Decreased expression of BTG3 was linked to carcinogenesis, aggressiveness, and prognosis of ovarian carcinoma.
Deng B, Zhao Y, Gou W, Chen S, Mao X, Takano Y
Tumour Biol. 2013; 34(5):2617-24.
PMID: 23657964
PMC: 3785705.
DOI: 10.1007/s13277-013-0811-2.
The role of the TOB1 gene in growth suppression of hepatocellular carcinoma.
Lin S, Zhu Q, Xu Y, Liu H, Zhang J, Xu J
Oncol Lett. 2012; 4(5):981-987.
PMID: 23162636
PMC: 3499594.
DOI: 10.3892/ol.2012.864.
C. elegans FOG-3/Tob can either promote or inhibit germline proliferation, depending on gene dosage and genetic context.
Snow J, Lee M, Verheyden J, Kroll-Conner P, Kimble J
Oncogene. 2012; 32(21):2614-21.
PMID: 22797076
PMC: 3475796.
DOI: 10.1038/onc.2012.291.
B-cell translocation gene 2 (BTG2) stimulates cellular antioxidant defenses through the antioxidant transcription factor NFE2L2 in human mammary epithelial cells.
Karve T, Rosen E
J Biol Chem. 2012; 287(37):31503-14.
PMID: 22493435
PMC: 3438983.
DOI: 10.1074/jbc.M112.367433.